Strata Critical Medical, Inc. SRTA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.74% | 87.45% | 83.54% | 36.70% | -33.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.74% | 87.45% | 83.54% | 36.70% | -33.61% |
| Cost of Revenue | 58.70% | 84.35% | 75.68% | 31.97% | -30.02% |
| Gross Profit | 68.92% | 100.16% | 132.75% | 54.69% | -44.92% |
| SG&A Expenses | -0.78% | 18.05% | -9.52% | -17.24% | -51.78% |
| Depreciation & Amortization | 1,761.52% | 264.22% | 107.00% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.01% | 66.50% | 49.50% | 15.57% | -37.91% |
| Operating Income | 0.87% | 66.39% | 66.58% | 91.86% | 61.94% |
| Income Before Tax | -208.48% | 249.01% | 27.48% | -71.62% | 69.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -208.48% | 249.01% | 27.48% | -71.62% | 69.90% |
| Earnings from Discontinued Operations | -- | 86.82% | -45.79% | 1,726.11% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -180.95% | 161.67% | 9.80% | 3,038.38% | 66.95% |
| EBIT | 0.87% | 66.39% | 66.58% | 91.86% | 61.94% |
| EBITDA | 215.58% | 125.99% | 94.19% | 97.28% | 67.88% |
| EPS Basic | -165.22% | 157.67% | 16.36% | 2,885.20% | 68.47% |
| Normalized Basic EPS | -16.09% | 101.60% | 88.47% | -- | -- |
| EPS Diluted | -165.22% | 157.67% | 19.27% | 2,874.00% | 69.33% |
| Normalized Diluted EPS | -16.09% | 101.60% | 88.47% | -- | -- |
| Average Basic Shares Outstanding | 6.05% | 6.80% | 7.84% | 5.65% | 4.76% |
| Average Diluted Shares Outstanding | 6.05% | 12.86% | 7.84% | 5.65% | 4.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |